(Q40765689)

23 September 2017

title

Evidence for the catalysis of dextromethorphan O-demethylation by a CYP2D6-like enzyme in pig liver (English)

1 reference

23 September 2017

Jurima-Romet M

1

1 reference

23 September 2017

Casley WL

series ordinal

2

1 reference

23 September 2017

Leblanc CA

series ordinal

3

1 reference

23 September 2017

Nowakowska M

series ordinal

4

1 reference

23 September 2017

publication date

1 June 2000

1 reference

23 September 2017

1 reference

23 September 2017

volume

14

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

253-263

1 reference

Assessment of the mouse as an experimental model for studying polymorphic oxidation of the sparteine/debrisoquine type

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Bufuralol 1'-hydroxylase activity of the rat. Strain differences and the effects of inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Fluoxetine and norfluoxetine are potent inhibitors of P450IID6--the source of the sparteine/debrisoquine oxidation polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Differences in caffeine 3-demethylation activity among inbred mouse strains: a comparison of hepatic Cyp1a2 gene expression between two inbred strains

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Stereo- and regioselectivity of hepatic oxidation in man--effect of the debrisoquine/sparteine phenotype on bufuralol hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Dextromethorphan O-demethylation in liver microsomes as a prototype reaction to monitor cytochrome P-450 db1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Early clinical experience with a hybrid bioartificial liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

"It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

A lipopolysaccharide-induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Mapping of porcine genes belonging to two different cytochrome P450 subfamilies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Hepatocyte liver-assist systems--a clinical update

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

Characterization of the P450 system in Göttingen minipigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2800%2900016-3

7 January 2021

10.1016/S0887-2333(00)00016-3

Identifiers

DOI

1 reference

23 September 2017

1 reference